Trend analysis on registration and declaration of radiopharmaceuticals in China based on the National Medical Products Administration review system from 2019 to 2025

XU Jingfei, QIAO Xinyu, WEI Liya, YU Jiang, LI Yiliang

主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
World Clinical Drug ›› 2026, Vol. 47 ›› Issue (4) : 449. DOI: 10.13683/j.wph.2026.04.014
Pharmacy administration

Trend analysis on registration and declaration of radiopharmaceuticals in China based on the National Medical Products Administration review system from 2019 to 2025

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 47(4): 449 https://doi.org/10.13683/j.wph.2026.04.014

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉